The Importance of Access to Treatment
People of color have long faced barriers to health care. See how this impacts your treatment for plaque psoriasis and how things may be changing. (Source: WebMD Health)
Source: WebMD Health - February 17, 2023 Category: Consumer Health News Source Type: news
The Importance of Access to Treatment
People of color are often not represented in research and clinical studies. Learn what this means for your psoriasis treatment and how it’s changing. (Source: WebMD Health)
Source: WebMD Health - February 17, 2023 Category: Consumer Health News Source Type: news
Why People of Color Are Commonly Misdiagnosed
Plaque psoriasis misdiagnosis is common in people of color. Learn the reasons why, how it can affect your health, and what you can do to get better care. (Source: WebMD Health)
Source: WebMD Health - February 17, 2023 Category: Consumer Health News Source Type: news
AI Model Differentiates Scalp Psoriasis From Seborrheic Dermatitis
THURSDAY, Feb. 16, 2023 -- A deep learning (DL) model based on dermatoscopic images can differentiate scalp psoriasis from seborrheic dermatitis, according to a study recently published in Frontiers in Medicine.
Zhang Yu, from Inner Mongolia Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2023 Category: Pharmaceuticals Source Type: news
PsA Prediction Tool Approaches Clinical Utility PsA Prediction Tool Approaches Clinical Utility
A tool to identify patients with psoriasis at high risk of psoriatic arthritis appears near to clinical application.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 16, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
Pediatric Psoriasis: Infection Risk Low With Systemic Meds Pediatric Psoriasis: Infection Risk Low With Systemic Meds
The results are from a large cohort study that estimated the 6-month rate of infections among children with psoriasis who started treatment with ustekinumab, etanercept, or methotrexate.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 16, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Diet-Induced Inflammation Not Linked to Psoriasis
WEDNESDAY, Feb. 15, 2023 -- Diet-induced inflammation seems not to be associated with psoriasis, according to a study published online Jan. 26 in the Journal of Dermatology.
Nouzhou Liu, from Sichuan University in Chengdu, China, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 15, 2023 Category: Pharmaceuticals Source Type: news
Selective TYK2 Inhibition in Chronic Plaque Psoriasis Selective TYK2 Inhibition in Chronic Plaque Psoriasis
This articles focuses on oral deucravacitinib, a first-in-class selective tyrosine kinase 2 inhibitor for the treatment of moderate-to-severe chronic plaque psoriasis.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 15, 2023 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Epidemiology of mental health comorbidity in patients with psoriasis: an analysis of trends from 1986 to 2019 - Liu L, Lin NX, Yu YT, Wang SH, Wang J, Cai XC, Wang CX, Zhang M, Li X, Li B.
BACKGROUND: The prevalence of mental disorders such as depression, anxiety, and suicide has increased in patients with psoriasis, although no study has systematically analyzed the epidemiology worldwide. OBJECTIVE: To explore the prevalence and inc... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
Targeting Specific Lipid Metabolic Pathway Linked to Reduced Psoriasis Risk
(MedPage Today) -- Inhibition of the PCSK9 pathway, best known for its links with dyslipidemia, had a significant association with a reduced risk of psoriasis, irrespective of lipid levels, according to a study focused on genetic variants.
Genetically... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 2, 2023 Category: Cardiology Source Type: news
Elevated PCSK9-Psoriasis Link: A New Target for Treatment? Elevated PCSK9-Psoriasis Link: A New Target for Treatment?
The study suggests that"PCSK9 inhibition is causally associated with reduced risk of psoriasis" and has implications for prevention and possibly treatment of psoriasis, the investigators say.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 1, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Bone x-ray scans predict fracture risk in psoriatic arthritis patients
Bone mineral density x-ray exams should be performed regularly in patients wit...Read more on AuntMinnie.comRelated Reading:
X-ray, MRI show link between steroid injections and worsened arthritis
NaF-PET shows bone formation in psoriatic arthritis patients
PET predicts treatment response in arthritis patients
Ultrasound shows heart disease risk from psoriasis
Pediatric patients go to the dogs for MRI anxiety relief (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 26, 2023 Category: Radiology Source Type: news
Psoriasis and PsA Show Distinctive Skin Microbiomes Psoriasis and PsA Show Distinctive Skin Microbiomes
No significant microbiome differences were noted between lesional and nonlesional skin swab samples from patients with psoriasis and psoriatic arthritis.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 26, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
NEW BRUNSWICK, N.J. – January 24, 2023 – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2022. “Our full year 2022 results reflect the continued strength and stability of our three business segments, despite macroeconomic challenges,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer. “I am inspired by our employees who make a difference in the health and lives of people around the world every day. As we look ahead to 2023, Johnson & Johnson is well-positioned to drive near-term growth, while also investing strategically to deliver long-term value...
Source: Johnson and Johnson - January 24, 2023 Category: Pharmaceuticals Source Type: news
Suicide risk and depression in patients with psoriasis - Bardazzi F, Bonci C, Sacchelli L, DI Altobrando A, Iommi M, Rucci P, Sacchelli P, Berardi D, Patrizi A, Tengattini V.
BACKGROUND: Psoriasis is associated with comorbid psychiatric conditions. However, its relationship with suicidality is not completely understood. The aim of this study was to analyze the prevalence and the correlates of depressive symptoms and suicide ris... (Source: SafetyLit)
Source: SafetyLit - January 23, 2023 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
